Some tumor cells were seen to have weak cytoplasmic IGF1R immunostaining (c-IGF1R 1+) in 121 (75.6%) cases and strong immunostaining (c-IGF1R 2+) in 41 (25.6%) cases. Here, IGF1R is linked to neoplasm.